Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | RCOR | Common Stock, par value $0.0001 per share | 1.4M | Sep 2, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | RCOR | Warrants | Sep 2, 2021 | Common Stock | 122K | $11.50 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | The securities reported herein may be deemed beneficially owned by each of: (i) RTW Investments, LP (the "Adviser"), which is deemed the beneficial owner of common stock (the "Shares") held by RTW Master Fund, Ltd. and one or more other private funds (collectively, the "Funds"), which are investment funds managed by the Adviser, and (ii) Roderick Wong, M.D., who serves as the Managing Partner and Chief Investment Officer of the Adviser, who have each filed separately. Dr. Wong exercises voting and dispositive control over the Shares held by the Adviser and is therefore deemed to be a beneficial owner of securities owned or controlled by the Adviser. Each of the Adviser and Dr. Wong disclaims beneficial ownership of the reported securities held by the Funds, except to the extent of its or his pecuniary interest therein. |
F2 | The reported amount in Table II reflects the total amount of Shares that may be received upon the conversion of such warrants, which entitles the holder thereof to purchase one-half (1/2) Share. |